New evidence added to the literature that paramagnetic rim lesions (PRLs) may be a biomarker of disability accumulation in ...

People with MS who experience progression independent of relapse activity tend to have more damage to their brain's white ...

Actress Christina Applegate shared her struggles with multiple sclerosis, describing it as the 'worst thing' she's ever ...

The Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...

Christina Applegate opens up about the daily tolls of life with multiple sclerosis: 'I can sometimes not do it.' ...

According to CEO Daniel Vitt, clinical and disability-related outcomes are more relevant than brain volume change for drug ...

Christina Applegate has had to deal with unkind speculation about how she might have contracted MS, as well as bizarre "cure" ...

Data from an open-label trial showed that foralumab treatment eased fatigue and lessened disability for some people with ...

Immunic’s lead oral small molecule has failed to hit the primary endpoint of a phase 2 trial in patients with progressive ...

Updates in relapsing-remitting MS from AAN 2025 examine neurofilament light protein level as a prognostic biomarker, safety ...

Reduction of confirmed disability worsening is widely considered to be the most recognized regulatory approval endpoint for registrational studies in progressive forms of multiple sclerosis (MS).